Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
bictegravir (Biktarvy) (1 trial)
emtricitabine (emtriva) (1 trial)
human papillomavirus 9-valent vaccine, recombinant (Gardasil 9) (1 trial)
ringer's lactate (1 trial)
tenofovir alafenamide (genvoya) (1 trial)
piperacillin (pipracil) (1 trial)
tazobactam (Zosyn) (1 trial)
axitinib (inlyta) (1 trial)
bone autograft (1 trial)
octreotide (sandostatin) (1 trial)
olive (1 trial)
Communicable Diseases (Phase 4)
Infections (Phase 4)
Neuroendocrine Tumors (Phase 2)
Papillomavirus Infections (Phase 4)
Pseudomonas Infections (Phase 3)
Trials (7 total)
Trial APIs (11 total)